BridgeMD
New treatment option for Breast Feeding, Exclusive
Official title Tactile/kinesthetic Stimulus Program
ClinicalTrials.gov ID: NCT05486663
What this study is testing
- What it's testing
- The study will be carried out as a prospective randomized controlled clinical study to determine the effect of tactile/kinesthetic stimulus program on preterm infants on transition time to full sucking, sucking success and hospital stay.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 28 to 32. Healthy volunteers may be eligible.
You may be able to join if
- Born between 28-32 weeks of gestation,
- Stable vital signs,
- 1st and 5th minute APGAR score between 6-10,
- Babies who have received mechanical ventilator or continuous positive air pressure (CPAP) or both support after 48 hours have passed after...
- Does not have an anomaly that will prevent feeding,
You likely can't join if
- IUGG,
- Infants with severe asphyxia,
- Babies born with low birth weight according to their gestational week,
- Having an anomaly that will prevent her from feeding,
- Babies with unstable vital signs,
- Babies with congenital anomalies or serious complications
See the full eligibility criteria
- Born between 28-32 weeks of gestation,
- Stable vital signs,
- 1st and 5th minute APGAR score between 6-10,
- Babies who have received mechanical ventilator or continuous positive air pressure (CPAP) or both support after 48 hours have passed after stabilization,
- Does not have an anomaly that will prevent feeding,
- Oral feeding decision has been made,
- Babies of mothers who are willing to breastfeed their babies,
- Babies of parents who volunteered to participate in the study will be taken.
- IUGG,
- Infants with severe asphyxia,
- Babies born with low birth weight according to their gestational week,
- Having an anomaly that will prevent her from feeding,
- Babies with unstable vital signs,
- Babies with congenital anomalies or serious complications
- Infants with intraventricular bleeding. Dismissal Criteria
- Babies whose oral feeding process is interrupted for more than 1 day due to neonatal problems.
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Eyalet/Yerleşke, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 28 weeks to 32 weeks. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Eyalet/Yerleşke, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.